Abstract 4631: Evaluation of the impact of homozygous MTAP truncations on the activity and selectivity of MTA-cooperative PRMT5 inhibitorsMatthew R. Tonini, Kimberly J. Briggs, Satoshi Yoda et al.|Cancer Research|2024Cited by 1
Abstract B098: Unbiased in vitro and in vivo drug anchor screens identify mechanisms of resistance and sensitization for MTA-cooperative PRMT5 inhibitors in MTAP-deleted cancer modelsSteven Lombardo, Teng Teng, Matthew R. Tonini et al.|Molecular Cancer Therapeutics|2023Cited by 0
Abstract 4608: Evaluation of the impact of homozygous MTAP truncations on the clinical activity of MTA-cooperative PRMT5 inhibitorsKimberly J. Briggs, Adam Crystal, Andre Mignault et al.|Cancer Research|2025Cited by 0